Financial reports
Current reports
8-K
Submission of Matters to a Vote of Security Holders
17 Jun 24
8-K
Departure of Directors or Certain Officers
13 Jun 24
8-K
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
14 May 24
8-K
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
1 Apr 24
8-K
Other Events
28 Mar 24
8-K
Entry into a Material Definitive Agreement
28 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
19 Jan 24
8-K
Departure of Directors or Certain Officers
3 Jan 24
8-K
Other Events
7 Dec 23
8-K
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results
9 Nov 23
Registration and prospectus
S-3
Shelf registration
30 Apr 24
424B5
Prospectus supplement for primary offering
15 Apr 24
S-8
Registration of securities for employees
1 Apr 24
S-8
Registration of securities for employees
2 Mar 23
S-3
Shelf registration
9 Nov 22
S-8
Registration of securities for employees
1 Mar 22
S-8
Registration of securities for employees
25 Oct 21
424B4
Prospectus supplement with pricing info
22 Oct 21
S-1/A
IPO registration (amended)
20 Oct 21
8-A12B
Registration of securities on exchange
18 Oct 21
Other
EFFECT
Notice of effectiveness
7 May 24
EFFECT
Notice of effectiveness
21 Nov 22
CORRESP
Correspondence with SEC
16 Nov 22
UPLOAD
Letter from SEC
15 Nov 22
EFFECT
Notice of effectiveness
22 Oct 21
SEC STAFF
SEC staff action: Order
22 Oct 21
CERT
Certification of approval for exchange listing
21 Oct 21
CORRESP
Correspondence with SEC
19 Oct 21
CORRESP
Correspondence with SEC
19 Oct 21
CORRESP
Correspondence with SEC
18 Oct 21